login

Primarily engaged in detecting drug activity in neuropathic pain by selective nerve fiber signal assay in pre-clinical and clinical studies

Primarily engaged in detecting drug activity in neuropathic pain by selective nerve fiber signal assay in pre-clinical and clinical studies

In vivo electrode traces establish a benchmark index for each subject and monitor the incidence of ectopia in patients with neuropathic pain

In vivo electrode traces establish a benchmark index for each subject and monitor the incidence of ectopia in patients with neuropathic pain

Continued ectopia in the presence of drug substance indicates a lack of effect, attenuation shows evidence of effectiveness

Continued ectopia in the presence of drug substance indicates a lack of effect, attenuation shows evidence of effectiveness

Frontpage Slideshow | Copyright © 2006-2010 JoomlaWorks, a business unit of Nuevvo Webware Ltd.

NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology that helps the pharmaceutical and biotechnology industries by assessing the activity of compounds through microneurography, providing evidence that is directly translational from basic research to clinical efficacy.


We are experts on the neurophysiological assessment of the peripheral and central nociceptive pathways, both preclinically and in humans.


Our services provide a direct translation of results from basic research to the clinical setting. We serve the pain drug development programs through a solid proof-of-concept model based on the detection and quantification of spontaneous activity in pain fibers.